Latest Updates On Three LSE Listed Stocks: SCLP, ESP And SYNT

  • Aug 20, 2019 BST
  • Team Kalkine
Latest Updates On Three LSE Listed Stocks: SCLP, ESP And SYNT

Scancell Holdings PLC

Scancell Holdings PLC (SCLP) is the United Kingdom based biopharmaceutical company having its products in the pre-clinical trial stages. The company, a spin-off of the University of Nottingham has been engaged in developing vaccines to prevent the development of cancer. It has so far managed to raise £23 million in funding its research activities and offers its cancer vaccine products under two heads, Immunobody and Moditope.

The company has its shares listed on the AIM at the London Stock Exchange where they get traded under the ticker name SCLP.

Recent News Update

The company on 20 August 2019 came out with its annual result for the financial year ending 30 April 2019. Along with that, the company also announced that it had added Vulpes a life science focused venture fund as its shareholders. Vulpes has infused £3.9 million in funding for 77, 559, 311 shares in the company.

Financial Updates of Scancell Holdings PLC for FY 2019 ending 30 April 2019 (£)

Source – Company Annual report publication for FY 2019

The company for the year ended 30 April 2019 reported development expenditure of £4.151 million compared to development expenditure of £2.855 million for the year ended 30 April 2018. The Operating loss for the year ended 30 April 2019 was £6.729 million, whereas it was Operating loss of £4.941 million for the period ended 30 April 2018. The loss before taxation for the year ended 30 April 2019 was £6.714 million, compared to a loss before taxation of £4.939 million for the period ended 30 April 2018. The net loss for the year ended 30 April 2019 was £5.627 million, whereas it was a net loss of £4.194 million for the year ended 30 April 2018. The higher loss for the year was on account of higher development expenditure. The earnings per share (diluted) of 1.45 pence was reported for the FY ended 30 April 2019, whereas for the period ended 30 April 2018, it was 1.34 pence per share. The company has not declared any dividend for the year ended 30 April 2019.

The share price performance of Scancell Holdings PLC at the London Stock Exchange

Daily Chart as on 20 August 2019, before the market close (Source: Thomson Reuters)

On 20 August 2019, at the time of writing of the report (before the market close, GMT 03.53 PM), SCLP shares were trading on the London Stock Exchange at GBX 6.72, down by 0.44 per cent over the previous day's closing price of GBX 6.75. The stock has a 52- week High of GBX 13.90, and a 52-week low of GBX 3.00. The total market capitalization of the company was around £31.47 million.

Outlook

The company’s vaccines have a promising future, its drug SCIB-1 from its ImmunoBody platform has recently entered stage II of clinical trials in the UK, with parallel clinical trials also going on in the United States of America. The interest shown by Vulpes venture fund in the company shows the prospects industry experts visualize regarding the value creation potential of the company’s products.

Empiric Student Property Plc

Empiric Student Property Plc (ESP) is the United Kingdom based REIT (Real estate Investment Trust) that invests in student accommodation based real estate in University towns and cities across the United Kingdom. In total it owns and manages about 70 assets with 7,400 beds across 30 town and cities across the United Kingdom, other than that, there are about 10 more property assets in its portfolio that are under development having 1,730 beds. Among its property portfolios are Centro Court, Brook Apartments and Edge apartments in London.

The REIT has its shares listed on the London Stock Exchange where its shares trade under the ticker name ESP.

Recent news update

The company on 20 August 2019 came out with its first half-yearly results for the period ending 30 June 2019 of the financial year 2019. The occupancy in its properties has improved to 97% during the reported six-month period, which has increased its pre-tax profits by 33 per cent over the figures for the six-month period ending 30 June 2018.

Financial Update of Empiric Student Property Plc for H1 2019 ending 30 June 2019 (£’000’s)

Source – Company Annual report publication for FY 2019

The company for the half-year ended 30 June 2019 reported revenue of £35.735 million compared to revenue of £31.289 million for half-year ended 30 June 2018. The Gross profit for the half-year ended 30 June 2019 was £24.490 million, whereas it was a gross profit of £19.502 million for the period ended 30 June 2018. The operating profit for the half-year ended 30 June 2019 was £35.140 million, compared to an operating profit of £28.229 million for the period ended 30 June 2018. The net profit for the half-year ended 30 June 2019 was £28.930 million, whereas it was a profit of £21.941 million for the half-year ended 30 June 2018. The higher profits for the half-year were on account of higher revenues, lower property expenses, lower finance expenses and improved valuation of investment properties. The earnings per share (diluted) of 4.77 pence was for the H1 ended 30 June 2019, whereas for the period ended 30 June 2018 it was 3.59 pence per share. The company declared a dividend of 1.25 pence per share for the half-year ended 30 June 2019, whereas for half-year ended 30 June 2018 it had declared a dividend of 1.82 pence per share.

The share price performance of Empiric Student Property Plc at the London Stock Exchange

Daily Chart as on 20 August 2019, after the market close (Source: Thomson Reuters)

On 20 August 2019, at the time of writing of the report (after the market close, GMT 04.26 PM), ESP shares were on the London Stock Exchange at GBX 92.80, up by 2.54 per cent over the previous day's closing price of GBX 90.5. The stock has a 52- week High of GBX 99.72, and a 52-week low of GBX 89.10. The total market capitalization of the company was around £546.69 million.

Outlook

The company’s business is flourishing with the increased arrival of students in the United Kingdom. One of the benefits of Lower British Pound value this year is that more international students will find the United Kingdom an attractive education destination, thereby giving student REIT companies like Empiric Student Property Plc good value creation opportunity.

Synthomer Plc

Synthomer Plc (SYNT) is a British company with interests in chemicals. The company has three divisions, Polymer Chemicals, Pharma Chemicals and Impact Chemicals. The company is 156 years old and is headquartered in London with its name changed to Synthomer Plc in 2012 from Yule Catto and Co.

The company’s shares are listed on the London stock exchange and trade under the ticker name SYNT. The company is also a constituent of the FTSE 250 index.

Recent News update

The company on 6 August 2019 came out with its first half-yearly results for the period ending 30 June 2019 for the financial year 2019. The company reported a sluggish performance on every counter, led by revenues that have shown a negative growth of 8.6 per cent.

Financial Update of Synthomer Plc for H1 2019 ending 30 June 2019 (£’000’s)

Source – Company Annual report publication for FY 2019

The company for the half-year ended 30 June 2019 reported revenue of £762.7 million compared to revenue of £833.8 million for half-year ended 30 June 2018. The operating profit for the half-year ended 30 June 2019 was £64.1 million, whereas it was operating profit of £89.4 million for the period ended 30 June 2018. The profit before tax for the half-year ended 30 June 2019 was £56.6 million, compared to a profit before tax of £86.2 million for the period ended 30 June 2018. The net profit for the half-year ended 30 June 2019 was £47.4 million, whereas it was a net profit of £74.8 million for the half-year ended 30 June 2018. The earnings per share (diluted) of 12.9 pence was for the H1 ended 30 June 2019, whereas for the period ended 30 June 2018 it was 19.1 pence per share. The company has not declared any dividend for the half-year ended 30 June 2019.

The share price performance of Synthomer Plc at the London Stock Exchange

Daily Chart as on 20 August 2019, after the market close (Source: Thomson Reuters)

On 20 August 2019, at the time of writing of the report (after the market close, GMT 04.26 PM), SYNTH shares on the London Stock Exchange were at GBX 295.6, down by 0.8 per cent over the previous day's closing price of GBX 298.0. The stock has a 52- week High of GBX 539.55, and a 52-week low of GBX 277.80. The total market capitalization of the company was around £1.25 billion

Outlook

The company is reeling under the effects of Brexit. It operates in one of those sectors that are the most effected by the resource side as well as sale side slump, being witnessed due to the impending effects of Brexit. The prospects of this sector largely depend on what new dynamics come to play following the date of passing of the Event (Brexit).

Comparative stock price performance chart of Scancell Holdings Plc, Empiric Student Property Plc and Synthomer Plc on the London Stock Exchange along with FTSE 250 index over the past year.

(Source – Thompson Reuters)

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK